Related Experiment Videos
Lactic acidosis and mitochondrial dysfunction in two children with peroxisomal disorders
R D Holmes1, K H Moore, J P Ofenstein
1Department of Pediatrics, William Beaumont Hospital, Royal Oak, MI 48073.
Journal of Inherited Metabolic Disease
|January 1, 1993
Summary
Peroxisomal disorders in children can disrupt fatty acid metabolism, leading to increased acyl-CoAs, impaired mitochondrial function, and lactic acidosis. This study highlights the link between peroxisomal defects and metabolic disturbances.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolic Disorders
Background:
- Peroxisomal disorders are linked to mitochondrial dysfunction and defects in oxidative phosphorylation.
- Peroxisomes and mitochondria are involved in fatty acid beta-oxidation, but their metabolic interplay is not fully understood.
- Peroxisomal beta-oxidation defects cause very long-chain fatty acid accumulation, potentially affecting mitochondrial function via altered fatty acyl-CoA pools.
Observation:
- Two children with generalized peroxisomal disorders (neonatal adrenoleukodystrophy and rhizomelic chondrodysplasia punctata) presented with lactic/pyruvic academia.
- Fibroblast cultures from these patients showed significantly inhibited lactate oxidation.
- Intracellular levels of acid-insoluble (long-chain and very long-chain) acyl-CoAs were elevated in both patients compared to controls.
Findings:
- Patients with generalized peroxisomal disorders exhibited increased intracellular acyl-CoA species.
- Pyruvate dehydrogenase (PDH) activity was significantly decreased in fibroblasts from both NALD and RCDP patients.
- The observed metabolic alterations correlated with clinical lactic/pyruvic academia.
Implications:
- This study demonstrates a direct link between peroxisomal beta-oxidation defects and impaired mitochondrial function in patients.
- Elevated intracellular acyl-CoAs in peroxisomal disorders contribute to mitochondrial dysfunction and lactic acidosis.
- Understanding these metabolic interactions is crucial for diagnosing and managing peroxisomal disorders and associated metabolic complications.